Replies to post #1414 on RespireRx Pharmaceuticals Inc (fka RSPI)

[Aiming4]

I wish Cortex had gotten good AD results before ADHD because ultimately I think the AD potential for Ampakines will DWARF the ADHD market.

But right now all of the focus on Cortex is due to ADHD.

I hope Cortex is driving a really hard bargain on the AD side with potential BP licensees, and is focused on getting a partner that will maximize the AD potential of Ampakines.